so with Philips the leading operator globally wants to use NiCo Lab every where in their machines + USD$1050 per scan rebatable by insurance + in US alone $USD 200 Bil spent on Strokes + Philips dominate in China and Europe + with massive valuations to EMV and 4DX which are way behind compared to NI Co lab: Common Sense dictates the valuation for NiCo got to be way higher than these EMV and 4DX.
- Forums
- IPOs
- Nico.lab Pre IPO
Nico.lab Pre IPO, page-258
-
- There are more pages in this discussion • 451 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)